Phillips O C, Capizzi L S
Clin Anesth. 1974;10(3):220-44.
Since the first report in 1846 on the use of anesthesia for a surgical procedure, deaths have occurred with practically every agent and technique used. Those mishaps of which we are aware are probably just a small segment of those that have actually occurred, since presently there is no widely used method for identifying anesthesia-associated deaths. Several sources of information are available, including the United States National Center for Health Statistics and articles in the medical literature. Neither of these encompasses more than a fraction of the total experience; in addition, the population upon which most reports are based and the number of anesthesias involved are usually not available as a denominator in determining the incidence of mishaps and the magnitude of the problem. Extrapolating from data from community anesthesia study committees and from population and operative figures, we can estimate that there are over 5,000 deaths associated with anesthesia in this country each year. This is 3 times as many as are caused by muscular dystrophy and multiple sclerosis, 15 times as many as with sickle cell anemia, 20 times as many as with myasthenia gravis and 40 times as many with poliomyelitis. We thus must recognize that anesthesia is an iatrogenic disease that deserves serious attention as a public health problem.
自1846年首次报道将麻醉用于外科手术以来,几乎每种使用过的麻醉剂和技术都曾导致死亡。我们所知晓的这些医疗事故可能只是实际发生的事故中的一小部分,因为目前尚无广泛应用的方法来识别与麻醉相关的死亡。有多种信息来源,包括美国国家卫生统计中心以及医学文献中的文章。但这些都只涵盖了全部经验的一小部分;此外,大多数报告所基于的人群以及所涉及的麻醉次数通常无法作为确定事故发生率和问题严重程度的分母。根据社区麻醉研究委员会的数据以及人口和手术数据进行推断,我们估计该国每年有超过5000例与麻醉相关的死亡。这是由肌肉萎缩症和多发性硬化症导致的死亡人数的3倍,镰状细胞贫血导致的死亡人数的15倍,重症肌无力导致的死亡人数的20倍,脊髓灰质炎导致的死亡人数的40倍。因此,我们必须认识到麻醉是一种医源性疾病,作为一个公共卫生问题值得认真关注。